NCT05756088View on ClinicalTrials.gov

Determining the Association of Microvascular Disease as Assessed by PET and Graft Injury by Donor Derived Cell Free DNA

SuspendedOBSERVATIONAL
Enrollment

88

Participants

Timeline

Start Date

December 31, 2025

Primary Completion Date

June 30, 2030

Study Completion Date

June 30, 2030

Conditions
Cardiac Allograft VasculopathyEndothelial DysfunctionMicrovascular Coronary Artery Disease
Interventions
DIAGNOSTIC_TEST

Blood draw to measure the levels of dd-cf DNA

Blood draw to measure the levels of dd-cf DNA.

Trial Locations (1)

06519

Yale New Haven Health, New Haven

Sponsors

Collaborators (1)

Natera, Inc.
All Listed Sponsors
collaborator

Yale Cardiovascular Research Group

OTHER

collaborator

Natera, Inc.

INDUSTRY

lead

Yale University

OTHER

NCT05756088 - Determining the Association of Microvascular Disease as Assessed by PET and Graft Injury by Donor Derived Cell Free DNA | Biotech Hunter | Biotech Hunter